Incyte wins EU backing for MacroGenics-partnered cancer...

2026-01-30 13:33:33 ET More on Incyte, MacroGenics What Investors Should Know Before Buying Incyte Incyte Corporation (INCY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Incyte: Buy For The Turnaround, Stay For The Pipeline Incyte marks late-stage trial win for Xencor-partnered lymphoma therapy Incyte Japan gains approval for Minjuvi with rituximab and lenalidomide to treat relapsed follicular lymphoma Read the full article on Seeking Alpha For further details see: Incyte wins EU backing for MacroGenics-partnered cancer drug in GIT indication